Literature DB >> 8168079

Developmental regulation of genomic imprinting of the IGF2 gene in human liver.

S M Davies1.   

Abstract

Control of the expression of the human insulin-like growth factor II gene is known to be complex, displaying both tissue-specific and developmental regulation. Insulin-like growth factor II is expressed at high levels in most tissues in the human fetus and appears to be important in fetal growth. In adult life, high levels of expression are found chiefly in liver, kidney, skin, nerve, and muscle tissue. Recent studies in the human fetus have demonstrated that in all tissues examined, including liver, the human insulin-like growth factor II gene is imprinted, with the paternally inherited allele expressed and the maternally inherited allele silent. The present study demonstrates that while the insulin-like growth factor gene is imprinted in human fetal liver, imprinting is relaxed in the second half of the first year of postnatal life, and thereafter the insulin-like growth factor gene is biallelically expressed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8168079

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  Postnatal establishment of allelic Gαs silencing as a plausible explanation for delayed onset of parathyroid hormone resistance owing to heterozygous Gαs disruption.

Authors:  Serap Turan; Eduardo Fernandez-Rebollo; Cumhur Aydin; Teuta Zoto; Monica Reyes; George Bounoutas; Min Chen; Lee S Weinstein; Reinhold G Erben; Vladimir Marshansky; Murat Bastepe
Journal:  J Bone Miner Res       Date:  2014-03       Impact factor: 6.741

2.  Increased In Vitro Osteopotential in SHED Associated with Higher IGF2 Expression When Compared with hASCs.

Authors:  Roberto Dalto Fanganiello; Felipe Augusto Andre Ishiy; Gerson Shigeru Kobayashi; Lucas Alvizi; Daniele Yumi Sunaga; Maria Rita Passos-Bueno
Journal:  Stem Cell Rev Rep       Date:  2015-08       Impact factor: 5.739

3.  The prevalence of loss of imprinting of H19 and IGF2 at birth.

Authors:  Rebecca C Rancourt; Holly R Harris; Ludovic Barault; Karin B Michels
Journal:  FASEB J       Date:  2013-04-25       Impact factor: 5.191

4.  Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis.

Authors:  J P Issa; P M Vertino; C D Boehm; I F Newsham; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 5.  Beckwith-Wiedemann syndrome and the insulin-like growth factor-II gene. Does the genotype explain the phenotype?

Authors:  D P Witte; K E Bove
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

Review 6.  The importance of imprinting in the human placenta.

Authors:  Jennifer M Frost; Gudrun E Moore
Journal:  PLoS Genet       Date:  2010-07-01       Impact factor: 5.917

7.  Evaluation of allelic expression of imprinted genes in adult human blood.

Authors:  Jennifer M Frost; Dave Monk; Taita Stojilkovic-Mikic; Kathryn Woodfine; Lyn S Chitty; Adele Murrell; Philip Stanier; Gudrun E Moore
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

Review 8.  Epigenetic regulation of the Igf2/H19 gene cluster.

Authors:  M Nordin; D Bergman; M Halje; W Engström; A Ward
Journal:  Cell Prolif       Date:  2014-04-16       Impact factor: 6.831

9.  A Loss of Epigenetic Control Can Promote Cell Death through Reversing the Balance of Pathways in a Signaling Network.

Authors:  Kiran G Vanaja; Winston Timp; Andrew P Feinberg; Andre Levchenko
Journal:  Mol Cell       Date:  2018-09-20       Impact factor: 17.970

10.  Maternal and paternal genomes differentially affect myofibre characteristics and muscle weights of bovine fetuses at midgestation.

Authors:  Ruidong Xiang; Mani Ghanipoor-Samami; William H Johns; Tanja Eindorf; David L Rutley; Zbigniew A Kruk; Carolyn J Fitzsimmons; Dana A Thomsen; Claire T Roberts; Brian M Burns; Gail I Anderson; Paul L Greenwood; Stefan Hiendleder
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.